- Home
- ZLAB vs GTX Comparison
ZLAB vs GTX Comparison
Compare ZLAB & GTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZLAB | GTX |
|---|---|---|
| Founded | 2013 | 2018 |
| Country | China | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 3.5B |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ZLAB | GTX |
|---|---|---|
| Price | $19.34 | $30.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $49.60 | $20.40 |
| AVG Volume (30 Days) | 641.2K | ★ 2.6M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.56% |
| EPS Growth | ★ 38.46 | 20.63 |
| EPS | N/A | ★ 0.49 |
| Revenue | $460,156,000.00 | ★ $3,584,000,000.00 |
| Revenue This Year | $9.75 | $4.16 |
| Revenue Next Year | $26.03 | $3.27 |
| P/E Ratio | ★ N/A | $60.47 |
| Revenue Growth | ★ 15.33 | 3.14 |
| 52 Week Low | $15.96 | $9.58 |
| 52 Week High | $44.34 | $29.89 |
Technical Indicators
Market Signals| Indicator | ZLAB | GTX |
|---|---|---|
| Relative Strength Index (RSI) | 42.01 | 86.70 |
| Support Level | $19.51 | $17.01 |
| Resistance Level | $19.64 | N/A |
| Average True Range (ATR) | 0.93 | 1.19 |
| MACD | -0.40 | 0.67 |
| Stochastic Oscillator | 25.76 | 99.18 |
Price Performance
Historical ComparisonAbout ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
About GTX Garrett Motion Inc.
Garrett Motion Inc designs, manufactures and sells engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (OEMs). The company is a technology leader with expertise in delivering products across gasoline, diesel, natural gas and electrified powertrains. The company also sells its technologies in the aftermarket through its distribution network. The company derives maximum of its revenue from Gas and geographically from Europe.